Thymus and tolerance. Is regulation the major function of the thymus?

Immunological Reviews

Volumn 182, Issue , 2001, Pages 33-57

  Durkin, Helen G ^a   Waksman, Byron H ^b  

^a SUNY Downstate Medical Center   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DNA; LYMPHOTOXIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN;

ANTIGEN PRESENTING CELL; AUTOIMMUNITY; DENDRITIC CELL; HELPER CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE MIGRATION; LYMPHOPOIESIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SUPPRESSOR CELL; T LYMPHOCYTE SUBPOPULATION; THYMOCYTE; THYMUS;

ANIMALS; AUTOANTIGENS; CHEMOTAXIS, LEUKOCYTE; DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULIN IDIOTYPES; RECEPTORS, ANTIGEN, T-CELL; SELF TOLERANCE; T-LYMPHOCYTES; THYMUS GLAND;

EID: 0035185362     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2001.1820103.x     Document Type: Review

References (311)

1. Activity of suppressor cells as a mechanism of tolerance
2. Tolerance, the thymus, and suppressor T-cells
3. The recirculation of lymphocytes from blood to lymph in the rat
4. A comparative histopathologic study of delayed hypersensitive reactions
5. Experimental allergic encephalomyelitis as prototype of the class of auto-allergic disease
6. Delayed hypersensitive reactions: A growing class of immunologic phenomena
7. The use of specific "lymphocyte" antisera to inhibit hypersensitive reactions of the "delayed" type
8. Initiation of immune responses by small lymphocytes
9. Immunological unresponsiveness
10. Role of the thymus in immune reactions in rats. II. Suppressive effect of thymectomy at birth on reactions of delayed (cellular) hypersensitivity and the circulating small lymphocyte
11. Role of the thymus in immune reactions in rats. III. Changes in the lymphoid organs of thymectomized rats
12. Immunological function of the thymus
13. Thymus-dependent areas in the lymphoid organs of neonatally thymectomized mice
14. Effect of thymectomy on "delayed" hypersensitive reactions
15. Role of the thymus in immune reactions in rats. I. The immunologic response to bovine serum albumin (antibody formation, Arthus reactivity, and delayed hypersensitivity) in rats thymectomized or splenectomized at various times after birth
16. Skin homograft survival in thymectomized mice
17. The production of runt disease in rats thymectomized at birth
18. Immunologic reactivity in neonatally thymectomized rats receiving competent lymphoid cells during immunization
19. Development of arthritis, periarthritis and periosteitis in rats given adjuvant
20. Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. II. Evidence that the disease is a disseminated immunologic response to exogenous antigen
21. Post-thymectomy autoimmune phenomena in mice. II. Morphologic observations
22. Thymus reproduction: Sex-linked dysgenesis of the gonad after neonatal thymectomy in mice
23. Bursectomy and thymectomy of obese strain (OS) chickens with spontaneous autoimmune thyroiditis and simultaneous experimental allergic encephalomyelitis
24. Analysis of autoimmunity through experimental models of thyroiditis and allergic encephalomyelitis
25. Role of the thymus in tolerance. VII. Distribution of nonaggregated and heat-aggregated bovine gamma globulin in lymphoid organs of normal newborn and adult rats
26. Actively acquired tolerance of foreign cells
27. On the possibility that thymus-mediated alloantigenic stimulation results in tolerance response
28. Adoptive tolerance; transfer of the tolerant state
29. On the mechanisms of immunologic self-recognition
30. Transplantation immunity and tolerance
31. Role of the thymus in tolerance. IV. Specific tolerance to homografts in neonatally thymectomized mice grafted with thymus from tolerant donors
32. Specific immunologic tolerance to bovine gamma globulin in thymectomized, irradiated rats grafted with thymus from tolerant donors
33. Role of the thymus in tolerance. I. Tolerance to bovine gamma globulin in thymectomized, irradiated rats grafted with thymus from tolerant donors
34. Role of the thymus in tolerance. II. Transfer of specific unresponsiveness to BSA with thymus grafting
35. The termination of immunological unresponsiveness to bovine serum albumin in rabbits. I. Quantitative and qualitative response to cross-reacting albumins
36. Role of the thymus in tolerance. VIII. Relative effectiveness of nonaggregated and heat-aggregated bovine gamma globulin, injected directly into lymphoid organs of normal rats in suppressing immune responsiveness
37. Role of the thymus in tolerance. III. Tolerance to bovine gamma globulin after direct injection of antigen into the shielded thymus of irradiated rats
38. Role of the thymus in tolerance. VI. Tolerance to bovine gamma globulin in rats given a low dose of irradiation and injection of nonaggregated or aggregated antigen into the shielded thymus
39. Reentry of T cells to the adult thymus is restricted to activated T cells
40. Effector T lymphocyte line cells migrate to the thymus and persist there
41. Role of the thymus in tolerance. X. "Suppressor" activity of antigen-stimulated rat thymocytes transferred to normal recipients
42. The thymic suppressor cell. I. Separation of subpopulations with suppressor activity
43. The thymic suppressor cell. II. Metabolic requirements of suppressor activity
44. Antigen-induced increase in migration of large cortical thymocytes (regulatory cells) to the marginal zone and red pulp of the spleen
45. Immunologically specific retention of long-lived lymphoid cells in antigenically stimulated lymph nodes
46. Homing of B-lymphocytes to follicles: Specific retention of immunologically committed cells
47. T-cell specificity for H-2 and Ir gene phenotype correlates with the phenotype of thymic antigen-presenting cells
48. Kinetic study of T lymphocytes after sensitization against soluble antigen
49. Separation of T cell subpopulations capable of DNA synthesis, lymphotoxin release, and regulation of antigen and phytohemagglutinin responses on the basis of density and adherence properties
50. Development and function of subpopulations of thymocytes and T lymphocytes
51. The splenic suppressor cell. I. Activity of thymus-dependent adherent cells. Changes with age and stress
52. The splenic suppressor cell. II. Suppression of the mixed lymphocyte reaction by thymus-dependent adherent cells
53. Inhibitory and stimulatory effects of concanavalin A on the response of mouse spleen cell suspensions to antigen. II. Evidence for separate stimulatory and inhibitory cells
54. Role of the thymus in tolerance. IX. Inhibition of experimental autoallergic encephalomyelitis by intrathymic injection of encephalitogen
55. Antigen-specific immunoregulation and autoimmune thyroiditis
56. Thymic expression of autoantigens correlates with resistance to autoimmune disease
57. Rapid loss of tolerance in weanling NZB and B-W F1 mice
58. Relative inability to induce tolerance in adult NZB and NZB-NZW F1 mice
59. Induction of immunologic tolerance in older New Zealand mice repopulated with young spleen, bone marrow, or thymus
60. Specific tolerance to sheep erythrocytes in mouse bone marrow cells
61. Thymic factors
62. Lymphocyte subpopulations in NZB mice: Deficit of thymus-dependent lymphocytes
63. Studies on the chemistry of anaphylaxis. III. Experiments with isolated proteins, especially those of the hen's egg
64. Inhibition of experimental drug allergy by prior feeding of the sensitizing agent
65. Immunologic supression after oral administration of antigen. I. Specific suppressor cells formed in rat Peyer's patches after oral administration of sheep erythrocytes and their systemic migration
66. Production of immunity and unresponsiveness in the mouse by feeding contact sensitizing agents and the role of suppressor cells in the Peyer's patches, mesenteric lymph nodes and other lymphoid tissues
67. Effects of antigen-feeding on intestinal and systemic immune responses. II. Suppression of delayed-type hypersensitivity reactions
68. Immunologic suppression after oral administration of antigen. III. Activation of suppressor-inducer cells in the Peyer's patches
69. + regulatory T cells by oral antigen administration
70. Oral tolerance: Mechanisms and therapeutic applications
71. Role of the thymus in tolerance. V. Suppressive effect of treatment with non-aggregated and aggregated bovine gamma-globulin on specific immune responses in normal adult rats
72. Use of thymectomized, irradiated rats to study immunogenicity of bovine gamma-globulin
73. Mechanisms of immunologic tolerance. I. Induction of tolerance to bovine gamma-globulin by injection of antigen into intact organs in vitro
74. Regression or survival of tumor homografts in mice pretreated with injections of lyophilized tissues
75. Immunological facilitation, a broadening of the concept of the enhancement phenomenon
76. Experimental endophthalmitis phaco-anaphylactica in rabbits
77. Experimental studies in allergic encephalomyelitis. Prevention and production (Note III)
78. Immunoregulation of experimental allergic encephalomyelitis: Conditions for induction of suppressor cells and analysis of mechanism
79. Suppressor cells in demyelinating disease: A new paradigm for the new millennium
80. Revisiting tolerance induced by autoantigen in incomplete Freund's adjuvant
81. Feedback inhibition of specifically sensitized lymphocytes
82. Two types of murine helper T-cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins
83. Role of the Fc fragment in the regulation of the primary immune response
84. Regulation of the immune response. X. Antigen-antibody complex inactivation of cells involved in adoptive transfer
85. Antibody-mediated immunosuppression of a cytotoxic cell response not involving a simple antigen-masking mechanism
86. Biological activities residing in the Fc region of immunoglobulin
87. Immunoglobulin-specific suppressor T cells
88. Receptors for immunoglobulin isotypes (FcR) on murine T cells. I. Multiple FcR expression on T lymphocytes and hybridoma T cell clones
89. Immune inhibitory receptors
90. Regulation of immune response by antibody. II. The effects of different classes of passive guinea pig antibody on humoral and cell-mediated immunity in rats
91. Fc receptor biology
92. Mampulating the immune system with immunoglobulin
93. Delayed hypersensitivity. 2. Induction of hypersensitivity in guinea pigs by means of antigen-antibody complexes
94. Regulatory effect of antibody on the immune response
95. Regulation of immune response by antibody, I. Suppression of antibody formation and concomitant enhancement of cell-mediated immunity by passive antibody
96. The role of lipid in the induction of hapten-specific delayed hypersensitivity and contact sensitivity
97. Induction of Fc receptors and immunoglobulin-binding factors in T-cell clones
98. Mechanism of immunologic unresponsiveness to picryl chloride and possible role of antibody mediated depression
99. Abrogation of sheep erythrocyte tolerance in rats by means of transfer of allogeneic lymphocytes
100. Regulation of homocytotropic antibody formation in the rat. VI. Inhibitory effect of thymocytes on the homocytotropic antibody response
101. Immunological paralysis to type III pneumococcal polysaccharide as assessed by an immuno-plaque procedure
102. Active suppression of immunoglobulin allotype synthesis. II. Transfer of suppressing factor with spleen cells
103. Cell interactions in the induction of tolerance: The role of thymic lymphocytes
104. Infectious immunological tolerance
105. Suppressor T cells
106. The infectiousness of antigenic competition: Conferrability of nonreactivity upon allogeneic T-cells
107. Contrasuppression. A novel immunoregulatory activity
108. A disquisition on suppressor T cells
109. Immunoregulatory T-cell pathways
110. Study on cellular events in postthymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis
111. Organ-specific autoimmune diseases induced in mice by elimination of T-cell subset. I. Evidence for the active participation of T-cells in natural self-tolerance: Deficit of a T-cell subset as a possible cause of autoimmune disease
112. Organ-specific autoimmune diseases induced in mice by elimination of T-cell subset. V. Neonatal administration of cyclosporin A causes autoimmune disease
113. Immunologic tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases
114. Lymphocytes from human newborns abrogate mitosis of their mothers' lymphocytes
115. Ontogeny of mouse lymphocyte function. II. Development of the ability to produce antibody is modulated by T lymphocytes
116. Mitogen-stimulated lymphoid cells from human newborns suppress the proliferation of maternal lymphocytes across a cell-impermeable membrane
117. Analysis of T regulatory cell surface markers and functional properties in multiple sclerosis
118. Immunology of multiple sclerosis
119. Blood lymphocyte β-adrenergic receptors in multiple sclerosis
120. T suppressor (TG) lymphocytes fluctuate in parallel with changes in the clinical course of patiens with multiple sclerosis
121. Functional analysis of two human T-cell subpopulations: Help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG
122. Loss of suppressor T cells in active multiple sclerosis
123. + T cells is mediated by interferon-γ and is defective in chronic progressive multiple sclerosis
124. Idiotype suppression. II. Amplification of a suppressor T cell with anti-idiotypic activity
125. Induction of specific immune unresponsiveness with purified mixed leukocyte culture-activated T lymphoblasts as auto-immunogen. III. Proof for the existence of autoanti-idiotypic killer T ceils and transfer of suppression to normal syngeneic recipients by T or B lymphocytes
126. Vaccination against autoimmune encephalomyelitis with T lymphocyte line ceils reactive against myelin basic protein
127. + T line cells
128. - splenic T cells from Lewis rats recovered from experimental autoimmune encephalomyelitis respond to encephalitogenic T cells that mediate this disorder
129. Analysis of the interactions between two molecules that are required for the expression of Ly-2 suppressor cell activity. Three different types of focusing events may be needed to deliver the suppressive signal
130. Induction or protection from experimental autoimmune encephalomyelitis depends on the cytokine secretion profile of TCR peptide-specific regulatory CD4 T cells
131. Suppressor T cell circuits
132. Cells control the HLA-linked low responsiveness to streptococcal antigen in man
133. HLA-linked genes controlling immune response and disease susceptibility
134. HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigen in humans
135. Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis: Analysis with anti-2H4 monoclonal antibody
136. Chronic-relapsing experimental autoimmune encephalomyelitis. Myelin basic protein induces suppression of blastogenesis during remissions but not during exacerbations
137. The role of antigen-specific T cell factors in the immune response
138. I-J as a restriction element in the suppressor T cell system
139. Réaction de précipitation spécifique des sérums d'animaux de même espéce
140. Immunologic differences between the 19S and 7S components of normal human gamma globulin
141. Immunologic suppression of idiotypic specificities
142. Anti-idiotypic antibodies against the receptor antibodies in myasthenia gravis
143. Idiotypic network connectivity and a possible cause of myasthenia gravis
144. Isolation of human anti-idiotypes broadly cross-reactive with anti-dsDNA antibodies from patients with systemic lupus erythematosus
145. Induction of a systemic lupus erythematosus-llke disease by a common human anti-DNA idiotype
146. Idiotypic cross-reaction of monoclonal human lupus antibodies
147. Towards a network theory of the immune system
148. Cellular basis of regulation of expression of idiotype. I. T-suppressor cells specific for MOPC 460 idiotype regulate the expression of cells secreting anti-TNP antibodies bearing 460 idiotype
149. Cytotoxic effect of lymphocyte-antigen interaction in delayed hypersensitivity
150. Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity II. Characterization of the phenomenon
151. Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. III. Analysis of mechanism
152. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin
153. Chronic inflammation caused by lymphotoxin is lymphoid neogenesis
154. The interferon
155. Release of virus inhibitor from tuberculin-sensitized peritoneal cells stimulated with antigen
156. Potentiation of cultured mouse thymocyte responses by factors released by peripheral leukocytes
157. Potentiation of T-lymphocyte responses to mitogens. I. The responding cell
158. Potentiation of T-lymphocyte responses to mitogens. II. The cellular source of potentiating mediators
159. Studies on the mechanism of fever accompanying delayed hypersensitivity: The role of the sensitized lymphocyte
160. Adherent cell function in murine T-lymphocyte antigen recognition. IV. Enhancement of murine T-cell antigen recognition by human leukocytic pyrogen
161. Regulatory substances produced by lymphocytes. I. Inhibitor of DNA synthesis in the rat
162. Regulatory substances produced by lymphocytes. II. Lymphotoxin in the rat
163. Regulatory substances produced by lymphocytes. III. Evidence that lymphotoxin and proliferation inhibitory factor are identical and differ from the inhibitor of DNA synthesis
164. The contribution of the cytokine concept to immunology
165. The effect of irradiation on the release of lymphocyte-activating factor (LAF)
166. Relationship between production and release of lymphocyte-activating factor (interleukin 1) by macrophages. I. Effects of various agents
167. Cytokine inhibition of DNA synthesis: Effect on cyclic adenosine monophosphate in lymphocytes
168. Regulatory substances produced by lymphocytes. VI. Cell cycle specificity of inhibitor of DNA synthesis action in L cells
169. Regulation of immune responses by TGF-β
170. Regulatory substances produced by lymphocytes. V. Production of inhibitor of DNA synthesis (IDS) by proliferating T-lymphocytes
171. Activation of distinct helper and suppressor T cells in experimental trypanosomiasis
172. Mechanisms of lymphocyte deletion by high concentrations of ligand (concanavalin A). I. Cyclic AMP levels and cell death in T-lymphocytes exposed to high concentrations of concanavalin A
173. Lymphocyte stimulation: Transfer of cellular hypersensitivity to antigen in vitro
174. Mediators of cellular immunity
175. Phenotypic similarity between T-cell antigen binding molecules
176. Studies on the role of the thymic environment in the induction of tolerance to MHC antigens
177. Induction of donor-specific unresponsiveness by intrathymic islet transplantation
178. Dendritic cell tolerogenicity and prospects for dendritic cell-based therapy of allograft rejection and autoimmunity
179. Kidney graft survival in rats without immunosuppressants after intrathymic glomerular transplantation
180. Induction of peripheral tolerance by intrathymic inoculation of soluble alloantigens: Evidence for the role of host antigen-presenting cells and suppressor cell mechanism
181. Intrathymic islet cell transplantation reduces β-cell autoimmunity and prevents diabetes in NOD/Lt mice
182. Thymic expression of the golli myelin basic protein in the SJL/J mouse
183. Endogenous myelin basic protein inactivates the high avidity T cell repertoire
184. Thymic selection by a single MHC/peptide ligand: Autoreactive T cells are low-affinity cells
185. Immune deviation - The third dimension of nondeletional T cell tolerance
186. The major myelin protein genes are expressed in the human thymus
187. High frequency of autoreactive myelin proeolipid protein-specific T cells in the periphery of naïve mice: Mechanisms of selection of the self-reactive repertoire
188. (Altered) self peptides and the regulation of self peptides in the peripheral T cell pool
189. The role of the thymus in modulating αδ T cell suppressor activity during experimental Tryponosoma cruzi infection
190. Dominant immunological tolerance
191. Evidence for a thymus-dependent form of tolerance that is not based on elimination or anergy of reactive T cells
192. The third function of the thymus
193. Immune tolerance and gene therapy in transplantation
194. Thymic dendritic cells and T cells develop simultaneously within the thymus from a common precursor population
195. Thymic dendritic cells
196. Early stages in the development of human T, natural killer and thymic dendritic cells
197. Regulation of NK 1.1 expression during lineage commitment of progenitor thymocytes
198. Lifespan of γ/δ T cells
199. Analysis of γδ T cells during thymic ontogeny and in peripheral lymphoid organs
200. Control of γδ T cell development
201. Does T cell tolerance require a dedicated antigen-presenting cell?
202. Dendritic cells and the control of immunity
203. T-cell priming by type-1 and type-2 polarized dendritic cells: The concept of a third signal
204. Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide
205. Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: Thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo
206. Immunological tolerance to a defined myelin basic protein antigen administered intrathymically
207. In vivo mechanisms of acquired thymic tolerance
208. J Immunol
209. Mechanisms of acquired thymic tolerance in vivo: Intrathymic injection of antigen induces apoptosis of thymocytes and peripheral T cell anergy
210. Targeted expression of MHC class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo
211. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion
212. Dendritic cells and the balance between transplant tolerance and immunity
213. Interleukin-10 inhibits T cell alloreaction induced by human dendritic cells
214. Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-β
215. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells
216. Myelin basic protein infused into cerebrospinal fluid suppresses experimental autoimmune encephalomyelitis
217. Monocyte-derived IL- 10-secreting dendritic cells in choroid plexus epithelium
218. T cells are just dying to accept grafts
219. Apoptosis - Gone but not forgotten
220. Intrathymic and extrathymic clonal deletion of T cells
221. A subclass of dendritic cells kills CD4 T cells via Fas/fas-ligand induced apoptosis
222. Thymic dendritic cells
223. Ex viva treatment of antigen-presenting cells with CTLA4Ig and encephalitogenic peptide prevents experimental autoimmune encephalomyelitis in the Lewis rat
224. T cell tolerance by clonal elimination in the thymus
225. + thymocytes
226. The thymus and T cell death
227. T cell tolerance and the thymus
228. Clonal deletion versus clonal anergy: The role of the thymus in inducing self tolerance
229. Non-deletional mechanisms of peripheral and central tolerance: Studies with transgenic mice with tissue-specific expression of a foreign MHC class I antigen
230. The thymus and the development of T lymphocytes
231. Different subpopulations of developing thymocytes are associated with adherent (macrophage) or nonadherent (dendritic) thymic rosettes
232. T cell recognition of self and altered self antigens
233. Several different cell surface molecules control negative selection of medullary thymocytes
234. T cell tolerance and the thymus
235. The cognitive paradigm and the immunological homunculus
236. Diversity of the anti-T-cell receptor immune response and its implications for T-cell vaccination therapy of multiple sclerosis
237. Immunoregulatory mechanisms of the eye
238. NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance
239. Direct thymic involvement in anterior chamber-associated immune deviation. Evidence for a nondeletional mechanism of centrally induced tolerance to extrathymic antigens in adult mice
240. Establishment of systemic tolerance through an immune privileged site requires the induction of regulatory NK T thymocytes by peripheral blood mononuclear cells
241. In situ tolerance within the central nervous system as a mechanism for preventing autoimmunity
242. Programming of lymphocyte responses to activation: Extrinsic factors, provided microenvironmentally, confer flexibility and compartmentalization to T-cell function
243. Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4
244. Regulation of murine lymphokine production in vivo. Ultraviolet radiation exposure depresses IL-2 and enhances IL-4 production by T cells through an IL-1-dependent mechanism
245. Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function
246. Antigen processing and presentation by intestinal epithelial cells - Polarity and complexity
247. The intestinal epithelial cell: Processing and presentation of antigen to the mucosal immune system
248. Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8
249. Thymus cell migration
250. Thymus cell migration. Quantitative aspects of cellular traffic from the thymus to the periphery in mice
251. Heat-shock proteins and γδ T ceils
252. + dendritic epidermal T cells as constituents of skin-associated lymphoid tissue
253. Gamma/delta T cells in fetal, neonatal, and adult rat lymphoid organs
254. Kinetic differences in unresponsiveness of thymus and bone marrow cells
255. In vivo behavior of homologous and heterologous thyroglobulin and induction of immunologic unresponsiveness to heterologous thyroglobulin
256. Induction, maintenance and termination of immunologic unresponsiveness to bovine thyroglobulin in rabbits
257. The role of suppressor T cells in the pathogenesis of common variable hypogammaglobulinemia
258. Suppressor cells in the regulation of the immune response
259. - T cell populations
260. Inhibition of CD40 signaling pathway in antigen presenting cells by T suppressor cells
261. T suppressor lymphocytes inhibit NF-κB-mediated transcription of CD86 gene in APC
262. Induction of MHC-class I restricted human suppressor T cells by peptide priming in vitro
263. + suppressor cells differentially affect the production of IFN-γ by effector cells of experimental autoimmune encephalomyelitis
264. + suppressor ceils inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanisms involving transforming growth factor-β
265. Endocytosis and dissociation of class I MHC molecules labeled with fluorescent β2-microgloblin
266. The problems of presentation of T cell receptor peptides by activated T cells
267. Do anergic T cells induce suppressor T lymphocytes through idiotypic interactions?
268. + T cells
269. Idiotype-reactive and anti-idiotype-reactive T lymphocytes in myasthenia gravis. Evidence for the involvement of different subpopulations of T helper lymphocytes
270. + T-cell line in vitro
271. Autoantibodies and immunological theories: An analytical review
272. + T cell responses to a self peptide
273. + T cells producing intracellular IL-4 is decreased in patients with multiple sclerosis
274. Activation antigens and signal transduction in lymphocyte activation
275. Induction of the antiergotypic response
276. Inhibition of autoimune T cell responses in the DA rat by bone marrow-derived NK cells in vitro: Implications for autoimmunity
277. Evidence for a thymus-dependent form of tolerance that is not based on elimination or anergy of reactive T cells
278. T cell-mediated maintenance of natural self-tolerance: Its breakdown as a possible cause of various autoimmune diseases
279. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance
280. Regulatory T cells and inflammatory bowel disease
281. Control of immune pathology by regulatory T cells
282. Immuno-regulation of experimental autoimmune encephalomyelitis: Editorial overview
283. Regulatory T cells in autoimmunity
284. The thymus contains a high frequency of cells that prevent autoimmune diabetes on transfer into prediabetic recipients
285. + naturally anergic and suppressive T cells
286. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation
287. Ionizing radiation and autoimmunity: Induction of autoimmune disease in mice by high dose fractionated total lymphoid irradiation and its prevention by inoculating normal T cells
288. + T cell subset that inhibits this autoimmune potential
289. - thymocytes
290. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
291. Immunopharmacologic modulation of experimental allergic encephalomyelitis: Low-dose cyclosporin treatment causes disease relapse and increased systemic T-cell-mediated and B-cell-mediated myelin-directed autoimmunity
292. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4
293. CTLA-4 mediates antigen-specific apoptosis of human cells
294. CTLA-4 can function as a negative regulator of T cell activation
295. Loss of CTLA-4 leads to massive lymphoproliferation and functional multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
296. CTLA-4 downregulates epitope spreading and mediates remission in relapsing experimental autoimmune encephalomyelitis
297. + regulatory ceils that control intestinal inflammation
298. + immunoregulatory T cells that control autoimmune diabetes
299. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells
300. High incidence of spontaneous autoimmune encephalomelitis in immunodeficient antimyelin basic protein T cell receptor transgeinc mice
301. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity
302. + T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis
303. + T cells that prevent spontaneous autoimmune encephalomyelitis
304. The neuropathology of chronic relapsing experimental allergic encephalomyelitis induced in the Lewis rat by inoculation with whole spinal cord and treatment with cyclosporin A